Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

Abstract Background Short-acting β2-agonist (SABA) bronchodilators help alleviate symptoms in chronic obstructive pulmonary disease (COPD) and may be a useful marker of symptom severity. This analysis investigated whether SABA use impacts treatment differences between maintenance dual- and mono-bron...

Full description

Bibliographic Details
Main Authors: F. Maltais, I. P. Naya, C. F. Vogelmeier, I. H. Boucot, P. W. Jones, L. Bjermer, L. Tombs, C. Compton, D. A. Lipson, E. M. Kerwin
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Respiratory Research
Subjects:
(3–10): dual bronchodilators
COPD
Symptoms
Lung function
Rescue therapy
SABA
Online Access:http://link.springer.com/article/10.1186/s12931-020-01451-8

Internet

http://link.springer.com/article/10.1186/s12931-020-01451-8

Similar Items